table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027
1.5.1 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Equine Pharmaceuticals and Supplements Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Equine Pharmaceuticals and Supplements Industry Impact
Chapter 2 Global Equine Pharmaceuticals and Supplements Competition by Types, Applications, and Top Regions and Countries
2.1 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Type
2.1.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Type (2016-2021)
2.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2016-2021)
2.2 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Application
2.2.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Application (2016-2021)
2.2.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2016-2021)
2.3 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Regions
2.3.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Equine Pharmaceuticals and Supplements Consumption by Regions (2016-2021)
4.2 North America Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
4.10 South America Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Equine Pharmaceuticals and Supplements Market Analysis
5.1 North America Equine Pharmaceuticals and Supplements Consumption and Value Analysis
5.1.1 North America Equine Pharmaceuticals and Supplements Market Under COVID-19
5.2 North America Equine Pharmaceuticals and Supplements Consumption Volume by Types
5.3 North America Equine Pharmaceuticals and Supplements Consumption Structure by Application
5.4 North America Equine Pharmaceuticals and Supplements Consumption by Top Countries
5.4.1 United States Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
5.4.2 Canada Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
5.4.3 Mexico Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 6 East Asia Equine Pharmaceuticals and Supplements Market Analysis
6.1 East Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis
6.1.1 East Asia Equine Pharmaceuticals and Supplements Market Under COVID-19
6.2 East Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types
6.3 East Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application
6.4 East Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries
6.4.1 China Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
6.4.2 Japan Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
6.4.3 South Korea Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 7 Europe Equine Pharmaceuticals and Supplements Market Analysis
7.1 Europe Equine Pharmaceuticals and Supplements Consumption and Value Analysis
7.1.1 Europe Equine Pharmaceuticals and Supplements Market Under COVID-19
7.2 Europe Equine Pharmaceuticals and Supplements Consumption Volume by Types
7.3 Europe Equine Pharmaceuticals and Supplements Consumption Structure by Application
7.4 Europe Equine Pharmaceuticals and Supplements Consumption by Top Countries
7.4.1 Germany Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.2 UK Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.3 France Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.4 Italy Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.5 Russia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.6 Spain Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.7 Netherlands Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.8 Switzerland Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
7.4.9 Poland Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 8 South Asia Equine Pharmaceuticals and Supplements Market Analysis
8.1 South Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis
8.1.1 South Asia Equine Pharmaceuticals and Supplements Market Under COVID-19
8.2 South Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types
8.3 South Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application
8.4 South Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries
8.4.1 India Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
8.4.2 Pakistan Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Equine Pharmaceuticals and Supplements Market Analysis
9.1 Southeast Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis
9.1.1 Southeast Asia Equine Pharmaceuticals and Supplements Market Under COVID-19
9.2 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types
9.3 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application
9.4 Southeast Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries
9.4.1 Indonesia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.2 Thailand Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.3 Singapore Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.4 Malaysia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.5 Philippines Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.6 Vietnam Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
9.4.7 Myanmar Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 10 Middle East Equine Pharmaceuticals and Supplements Market Analysis
10.1 Middle East Equine Pharmaceuticals and Supplements Consumption and Value Analysis
10.1.1 Middle East Equine Pharmaceuticals and Supplements Market Under COVID-19
10.2 Middle East Equine Pharmaceuticals and Supplements Consumption Volume by Types
10.3 Middle East Equine Pharmaceuticals and Supplements Consumption Structure by Application
10.4 Middle East Equine Pharmaceuticals and Supplements Consumption by Top Countries
10.4.1 Turkey Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.3 Iran Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.5 Israel Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.6 Iraq Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.7 Qatar Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.8 Kuwait Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
10.4.9 Oman Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 11 Africa Equine Pharmaceuticals and Supplements Market Analysis
11.1 Africa Equine Pharmaceuticals and Supplements Consumption and Value Analysis
11.1.1 Africa Equine Pharmaceuticals and Supplements Market Under COVID-19
11.2 Africa Equine Pharmaceuticals and Supplements Consumption Volume by Types
11.3 Africa Equine Pharmaceuticals and Supplements Consumption Structure by Application
11.4 Africa Equine Pharmaceuticals and Supplements Consumption by Top Countries
11.4.1 Nigeria Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
11.4.2 South Africa Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
11.4.3 Egypt Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
11.4.4 Algeria Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
11.4.5 Morocco Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 12 Oceania Equine Pharmaceuticals and Supplements Market Analysis
12.1 Oceania Equine Pharmaceuticals and Supplements Consumption and Value Analysis
12.2 Oceania Equine Pharmaceuticals and Supplements Consumption Volume by Types
12.3 Oceania Equine Pharmaceuticals and Supplements Consumption Structure by Application
12.4 Oceania Equine Pharmaceuticals and Supplements Consumption by Top Countries
12.4.1 Australia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
12.4.2 New Zealand Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 13 South America Equine Pharmaceuticals and Supplements Market Analysis
13.1 South America Equine Pharmaceuticals and Supplements Consumption and Value Analysis
13.1.1 South America Equine Pharmaceuticals and Supplements Market Under COVID-19
13.2 South America Equine Pharmaceuticals and Supplements Consumption Volume by Types
13.3 South America Equine Pharmaceuticals and Supplements Consumption Structure by Application
13.4 South America Equine Pharmaceuticals and Supplements Consumption Volume by Major Countries
13.4.1 Brazil Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.2 Argentina Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.3 Columbia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.4 Chile Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.5 Venezuela Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.6 Peru Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
13.4.8 Ecuador Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Equine Pharmaceuticals and Supplements Business
14.1 Boehringer Ingelheim
14.1.1 Boehringer Ingelheim Company Profile
14.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Specification
14.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Virbac
14.2.1 Virbac Company Profile
14.2.2 Virbac Equine Pharmaceuticals and Supplements Product Specification
14.2.3 Virbac Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Bayer Animal Health
14.3.1 Bayer Animal Health Company Profile
14.3.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Specification
14.3.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Merck Animal Health
14.4.1 Merck Animal Health Company Profile
14.4.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Specification
14.4.3 Merck Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 CEVA
14.5.1 CEVA Company Profile
14.5.2 CEVA Equine Pharmaceuticals and Supplements Product Specification
14.5.3 CEVA Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Zoetis
14.6.1 Zoetis Company Profile
14.6.2 Zoetis Equine Pharmaceuticals and Supplements Product Specification
14.6.3 Zoetis Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Kyoritsu Seiyaku
14.7.1 Kyoritsu Seiyaku Company Profile
14.7.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Specification
14.7.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Dechra Veterinary Products
14.8.1 Dechra Veterinary Products Company Profile
14.8.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Specification
14.8.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Elanco Animal Health
14.9.1 Elanco Animal Health Company Profile
14.9.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Specification
14.9.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Norbrook Equine
14.10.1 Norbrook Equine Company Profile
14.10.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Specification
14.10.3 Norbrook Equine Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Vetoquinol
14.11.1 Vetoquinol Company Profile
14.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Specification
14.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Ouro Fino Saude
14.12.1 Ouro Fino Saude Company Profile
14.12.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Specification
14.12.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Protexin Healthcare
14.13.1 Protexin Healthcare Company Profile
14.13.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Specification
14.13.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Audevard
14.14.1 Audevard Company Profile
14.14.2 Audevard Equine Pharmaceuticals and Supplements Product Specification
14.14.3 Audevard Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Equine Pharmaceuticals and Supplements Market Forecast (2022-2027)
15.1 Global Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Equine Pharmaceuticals and Supplements Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Equine Pharmaceuticals and Supplements Value and Growth Rate Forecast (2022-2027)
15.2 Global Equine Pharmaceuticals and Supplements Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Equine Pharmaceuticals and Supplements Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Equine Pharmaceuticals and Supplements Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast by Type (2022-2027)
15.3.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2022-2027)
15.3.3 Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2022-2027)
15.4 Global Equine Pharmaceuticals and Supplements Consumption Volume Forecast by Application (2022-2027)
15.5 Equine Pharmaceuticals and Supplements Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
